Healthcare

The healthcare industry is in the midst of a long wave of consolidation.

In addition to the usual motive of attaining critical mass to survive, healthcare companies are especially sensitive to the need for new technologies and access to crossborder markets. Healthcare companies are attractive for international M&A.

With healthcare experts located around the world, Clairfield understands this complicated sector and is perfectly positioned to help clients take advantage of market conditions, focusing on the following segments:

Dental care

Diagnostics

Home health service and residential care

Hospital & clinics

Medical devices/medtech

Pharmaceuticals

Medical distributors

Social services/mental health

Download our latest publication:

Clairfield Annual Outlook 2020 19

Recent healthcare transactions:

ASX‐listed National Veterinary Care Ltd, the Australian and New Zealand
veterinary services provider, has announced that it has entered into a binding
Scheme Implementation Deed with VetPartners.

Krankenhaus Ingelheim gGmbH, a German hospital, was sold by the University Clinic Mainz and the City of Ingelheim to Ccare AG, a German healthcare services group.

Sterimed, a world leader in the medical packaging sector, completed the acquisition of Especialistas en Esterilizacion y Envase (Grupo EEE), a Mexican-based major player in sterilization packaging and infection prevention solutions.

Italian pharmaceutical multinational Zambon acquired the biotech Breath Therapeutics at an initial price of 140 million euros and with the possibility of reaching a total of 500 million euros.

Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Subscribe to our mailing list
ErrorHere